1544 related articles for article (PubMed ID: 27568655)
1. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
[TBL] [Abstract][Full Text] [Related]
2. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.
Wegelin O; Exterkate L; van der Leest M; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
Eur Urol; 2019 Apr; 75(4):582-590. PubMed ID: 30522912
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate: a systematic review and meta-analysis.
Bass EJ; Pantovic A; Connor MJ; Loeb S; Rastinehad AR; Winkler M; Gabe R; Ahmed HU
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):174-179. PubMed ID: 34548624
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.
Arsov C; Rabenalt R; Blondin D; Quentin M; Hiester A; Godehardt E; Gabbert HE; Becker N; Antoch G; Albers P; Schimmöller L
Eur Urol; 2015 Oct; 68(4):713-20. PubMed ID: 26116294
[TBL] [Abstract][Full Text] [Related]
5. Elastic Versus Rigid Image Registration in Magnetic Resonance Imaging-transrectal Ultrasound Fusion Prostate Biopsy: A Systematic Review and Meta-analysis.
Venderink W; de Rooij M; Sedelaar JPM; Huisman HJ; Fütterer JJ
Eur Urol Focus; 2018 Mar; 4(2):219-227. PubMed ID: 28753777
[TBL] [Abstract][Full Text] [Related]
6. Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?
Exterkate L; Wegelin O; Barentsz JO; van der Leest MG; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; van Melick HHE; Somford DM
Eur Urol Oncol; 2020 Apr; 3(2):216-223. PubMed ID: 31239236
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.
Schoots IG; Roobol MJ; Nieboer D; Bangma CH; Steyerberg EW; Hunink MG
Eur Urol; 2015 Sep; 68(3):438-50. PubMed ID: 25480312
[TBL] [Abstract][Full Text] [Related]
8. A Prospective Comparison of Transrectal Standard, Cognitive, Transperineal Fusion, and Mapping Prostate Biopsy for Cancer Detection.
Petov V; Bazarkin A; Morozov A; Taratkin M; Ganzha T; Danilov S; Chernov Y; Chinenov D; Rzayev R; Suvorov A; Amosov A; Fajkovic H; Enikeev D; Krupinov G
J Endourol; 2023 Aug; 37(8):940-947. PubMed ID: 37294206
[No Abstract] [Full Text] [Related]
9. Cognitive Versus Software Fusion for MRI-targeted Biopsy: Experience Before and After Implementation of Fusion.
Monda SM; Vetter JM; Andriole GL; Fowler KJ; Shetty AS; Weese JR; Kim EH
Urology; 2018 Sep; 119():115-120. PubMed ID: 29940232
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Magnetic Resonance Imaging-stratified Clinical Pathways and Systematic Transrectal Ultrasound-guided Biopsy Pathway for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Woo S; Suh CH; Eastham JA; Zelefsky MJ; Morris MJ; Abida W; Scher HI; Sidlow R; Becker AS; Wibmer AG; Hricak H; Vargas HA
Eur Urol Oncol; 2019 Nov; 2(6):605-616. PubMed ID: 31204311
[TBL] [Abstract][Full Text] [Related]
11. Complications and Adverse Events of Three Magnetic Resonance Imaging-based Target Biopsy Techniques in the Diagnosis of Prostate Cancer Among Men with Prior Negative Biopsies: Results from the FUTURE Trial, a Multicentre Randomised Controlled Trial.
Wegelin O; Exterkate L; van der Leest M; Kelder JC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
Eur Urol Oncol; 2019 Nov; 2(6):617-624. PubMed ID: 31519516
[TBL] [Abstract][Full Text] [Related]
12. Magnetic Resonance Imaging Guided Prostate Biopsy in Patients with ≥ One Negative Systematic Transrectal Ultrasound-Guided Biopsy: A Systemic Review and Meta-Analysis.
Lan H; Zhou Y; Lin G; Zhao H; Wu G
Cancer Invest; 2022 Oct; 40(9):789-798. PubMed ID: 36062985
[TBL] [Abstract][Full Text] [Related]
13. Comparison of patient comfort between MR-guided in-bore and MRI/ultrasound fusion-guided prostate biopsies within a prospective randomized trial.
Arsov C; Rabenalt R; Quentin M; Hiester A; Blondin D; Albers P; Antoch G; Schimmöller L
World J Urol; 2016 Feb; 34(2):215-20. PubMed ID: 26055645
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Imaging-guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate.
Costa DN; Goldberg K; Leon AD; Lotan Y; Xi Y; Aziz M; Freifeld Y; Margulis V; Raj G; Roehrborn CG; Hornberger B; Desai N; Bagrodia A; Francis F; Pedrosa I; Cadeddu JA
Eur Urol Oncol; 2019 Jul; 2(4):397-404. PubMed ID: 31277776
[TBL] [Abstract][Full Text] [Related]
15. Transrectal ultrasound-guided targeted biopsy of transition zone prostate cancer under cognitive registration with prebiopsy MRI and sonographic findings.
Won SY; Cho NH; Choi YD; Park SY
Clin Radiol; 2020 Feb; 75(2):157.e21-157.e27. PubMed ID: 31677880
[TBL] [Abstract][Full Text] [Related]
16. Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review.
Valerio M; Donaldson I; Emberton M; Ehdaie B; Hadaschik BA; Marks LS; Mozer P; Rastinehad AR; Ahmed HU
Eur Urol; 2015 Jul; 68(1):8-19. PubMed ID: 25454618
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging-transrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer.
Shoji S
Investig Clin Urol; 2019 Jan; 60(1):4-13. PubMed ID: 30637355
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric MRI-targeted TRUS prostate biopsies using visual registration.
Puech P; Ouzzane A; Gaillard V; Betrouni N; Renard B; Villers A; Lemaitre L
Biomed Res Int; 2014; 2014():819360. PubMed ID: 25525605
[TBL] [Abstract][Full Text] [Related]
20. Is targeted magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy enough for the detection of prostate cancer in patients with PI-RADS ≥3: Results of a prospective, randomized clinical trial.
Zhang J; Zhu A; Sun D; Guo S; Zhang H; Liu S; Fu Q; Zhang K
J Cancer Res Ther; 2020; 16(7):1698-1702. PubMed ID: 33565519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]